Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

No Comments

tgAAV-CFTR research results published in The Lancet

June 11, 1998

No Comments

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

No Comments

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

No Comments

Genome Therapeutics reaches milestone in Schering-Plough alliance

June 9, 1998

No Comments

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

No Comments

Clinical protocol for phase I/II testing of tgAAV-CFTR

June 5, 1998

No Comments

Zyrtec approved for use in children as young as two years

June 5, 1998

No Comments

Neurokinin antagonists in the pipeline at Schering-Plough

June 4, 1998

No Comments

Byk Gulden's new PDE IV inhibitors

June 4, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Respiratory
RSS

New antiallergic and antiinflammatory compounds developed by Astra researchers

tgAAV-CFTR research results published in The Lancet

Pfizer discloses indazole inhibitors of PDE and TNF production

Byk Gulden patents another series of thiazole PDE IV inhibitors

Genome Therapeutics reaches milestone in Schering-Plough alliance

Bronchotherapeutic agents in development at Byk Gulden

Clinical protocol for phase I/II testing of tgAAV-CFTR

Zyrtec approved for use in children as young as two years

Neurokinin antagonists in the pipeline at Schering-Plough

Byk Gulden's new PDE IV inhibitors

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Respiratory RSS

Respiratory
RSS